Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.

Gustin KM, Maines TR, Belser JA, van Hoeven N, Lu X, Dong L, Isakova-Sivak I, Chen LM, Voeten JT, Heldens JG, van den Bosch H, Cox NJ, Tumpey TM, Klimov AI, Rudenko L, Donis RO, Katz JM.

J Infect Dis. 2011 Nov 15;204(10):1491-9. doi: 10.1093/infdis/jir596. Epub 2011 Sep 28.

PMID:
21957153
3.

Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.

Zheng D, Yi Y, Chen Z.

Viruses. 2012 Dec 10;4(12):3589-605. doi: 10.3390/v4123589. Review.

4.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892
5.

Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza.

Kiseleva I, Larionova N, Rudenko L.

Open Microbiol J. 2017 Nov 30;11:316-329. doi: 10.2174/1874285801711010316. eCollection 2017. Review.

6.

Design of alternative live attenuated influenza virus vaccines.

Finch C, Li W, Perez DR.

Curr Top Microbiol Immunol. 2015;386:205-35. doi: 10.1007/82_2014_404. Review.

PMID:
25005928
7.

Virus-vectored influenza virus vaccines.

Tripp RA, Tompkins SM.

Viruses. 2014 Aug 7;6(8):3055-79. doi: 10.3390/v6083055. Review.

Supplemental Content

Support Center